Cargando…

Impacts of tissue-type plasminogen activator (tPA) on neuronal survival

Tissue-type plasminogen activator (tPA) a serine protease is constituted of five functional domains through which it interacts with different substrates, binding proteins, and receptors. In the last years, great interest has been given to the clinical relevance of targeting tPA in different diseases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chevilley, Arnaud, Lesept, Flavie, Lenoir, Sophie, Ali, Carine, Parcq, Jérôme, Vivien, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607783/ https://www.ncbi.nlm.nih.gov/pubmed/26528141 http://dx.doi.org/10.3389/fncel.2015.00415

Ejemplares similares

Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR
por: Bertrand, T, et al.
Publicado: (2015)

Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
por: Lenoir, Sophie, et al.
Publicado: (2019)

Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors
por: Lesept, Flavie, et al.
Publicado: (2016)

Modulations of the neuronal trafficking of tissue-type plasminogen activator (tPA) influences glutamate release
por: Varangot, Alexandre, et al.
Publicado: (2023)

Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden
por: Tomadesso, Clémence, et al.
Publicado: (2022)

Tissue-type Plasminogen Activator (tPA) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate
por: Jeanneret, Valerie, et al.
Publicado: (2016)

Tissue plasminogen activator (tPA) attenuates propofol-induced apoptosis in developing hippocampal neurons
por: Liang, Chao, et al.
Publicado: (2016)

Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival
por: Hedou, Elodie, et al.
Publicado: (2021)

Blood tissue Plasminogen Activator (tPA) of liver origin contributes to neurovascular coupling involving brain endothelial N-Methyl-D-Aspartate (NMDA) receptors
por: Furon, Jonathane, et al.
Publicado: (2023)

The Influence of Tissue Plasminogen Activator I/D Polymorphism on the tPA Response to Exercise
por: COUGHLIN, ADAM M., et al.
Publicado: (2018)

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo
por: Jullienne, Amandine, et al.
Publicado: (2011)

Alu DNA Polymorphism of Human Tissue Plasminogen Activator (tPA) Gene in Diabetic Jordanian Patients
por: Yasin, Salem R., et al.
Publicado: (2019)

Tissue plasminogen activator prevents white matter damage following stroke
por: Correa, Fernando, et al.
Publicado: (2011)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

Tissue‐type plasminogen activator (tPA) homozygous Tyr471His mutation associates with thromboembolic disease
por: Tao, Yanyi, et al.
Publicado: (2023)

tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)

Enhanced control of bioactivity of tissue plasminogen activator (tPA) through domain-directed enzymatic oxidation of terminal galactose
por: Mahdi, Wael A., et al.
Publicado: (2022)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
por: Mennesson, Marie, et al.
Publicado: (2023)

PSUN171 CORRELATIONS BETWEEN SERUM AND TEAR PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE PLASMINOGEN ACTIVATOR (tPA) IN PATIENTS WITH DIABETIC RETINOPATHY
por: Jasmiad, Nurbadriah, et al.
Publicado: (2022)

Variability in the Perception of Informed Consent for IV-tPA during Telestroke Consultation
por: Thomas, Lisa, et al.
Publicado: (2012)

tPA Deficiency in Mice Leads to Rearrangement in the Cerebrovascular Tree and Cerebroventricular Malformations
por: Stefanitsch, Christina, et al.
Publicado: (2015)

Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter?
por: Boone, Niels Willem, et al.
Publicado: (2012)

Regulated Proteolytic Processing of Reelin through Interplay of Tissue Plasminogen Activator (tPA), ADAMTS-4, ADAMTS-5, and Their Modulators
por: Krstic, Dimitrije, et al.
Publicado: (2012)

Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
por: Marsh, Elisabeth B., et al.
Publicado: (2013)

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer
por: Witte, J H de, et al.
Publicado: (1999)

PACAP Interacts with PAC(1) Receptors to Induce Tissue Plasminogen Activator (tPA) Expression and Activity in Schwann Cell-Like Cultures
por: Castorina, Alessandro, et al.
Publicado: (2015)

The effect of prehospital notification by emergency medical service on outcomes in patients receiving recombinant tissue-type plasminogen activator (r-tPA)
por: Rafie, Shahram, et al.
Publicado: (2022)

Low-Dose Slow Infusion Tissue Plasminogen Activator (tPA) in Treatment of Thrombotic Coronary Artery Occlusions: Case Series and Literature Review
por: Akçay, Murat, et al.
Publicado: (2022)

To tPA or Not to tPA: Two Medical-Legal Misadventures of Diagnosing a Cerebrovascular Accident as a Stroke Mimic
por: Moore, Malia J., et al.
Publicado: (2019)

Effect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke
por: Lapchak, Paul A, et al.
Publicado: (2014)

Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure
por: Lépine, Matthieu, et al.
Publicado: (2022)

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014)

Double-Gene Copromoting Expression Analysis in tPA/GH Transgenic Goat Mammary Epithelial Cells and Thrombolytic Activity of tPA In Vitro
por: Song, Shaozheng, et al.
Publicado: (2022)

High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study
por: Eliasson, Mats CE, et al.
Publicado: (2003)

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis
por: Choudhury, Rashikh, et al.
Publicado: (2020)

Transfusion of Resting Platelets Reduces Brain Hemorrhage After Intracerebral Hemorrhage and tPA-Induced Hemorrhage After Cerebral Ischemia
por: Luo, Haiyu, et al.
Publicado: (2019)

Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)
por: Liberale, Luca, et al.
Publicado: (2020)

Unintentional intramuscular administration of tPA/DNase for pleural infection
por: Popowicz, Natalia, et al.
Publicado: (2014)

Exosome-Coated tPA/Catalase Nanoformulation for Thrombolytic Therapy
por: Khalil, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v0qeqg2nkc21c5fq2q1q0eerel